Delivery Order SPE2DR25D1202-SPE2DR26F74HL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,028.40 to AmerisourceBergen Drug Corp for the supply of Misoprostol 200 mcg tablets in unit-dose packaging (100 tablets per package) on January 15, 2026. This firm fixed-price, non-set-aside contract is scheduled for completion by January 16, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,350.19 to AmerisourceBergen Drug Corp for the supply of Misoprostol 200 microgram tablets in unit dose packaging (100 count) with an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Misoprostol 100 MCG tablets in unit dose packaging of 100s, with a ceiling value of $1,583.98 and an ultimate completion date of December 12, 2025. This firm fixed-price delivery order represents a non-competitive award and is classified as a child contract under AmerisourceBergen's larger procurement vehicle. The place of performance is the company's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,288.56 to AmerisourceBergen Drug Corp for the supply of Misoprostol 200 microgram tablets in unit dose packages of 100 units. This competitively awarded, firm fixed-price delivery order was executed on January 22, 2026, with an ultimate completion date of January 23, 2026. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, is for the delivery of 60 count bottles of 200 mcg Misoprostol tablets, with a potential value of one hundred thirty-two dollars. The order was awarded on October 19, 2023 under Amerisourcebergen's corporate office blanket purchase agreement, for delivery by October 20, 2023. No set-aside designation was applied to this firm fixed price order. The Defense Logistics Agency manages the global supply...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $2,264.14 firm fixed price delivery order for the supply of 4564912456 - Misoprostol 100 MCG Tablet UD 100S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mifepristone 300 mg tablets in a 28-day supply quantity, with a ceiling value of $84,653.44. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's broader pharmaceutical...
- The Defense Logistics Agency awarded a $69,729.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mifepristone 300 mg tablets (28-count) with an ultimate completion date of December 5, 2025. The award, issued on December 4, 2025, is non-set-aside and competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a $1,157.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac-Misoprostol 75-0.2 mg tablets (60-count units) with a completion date of January 26, 2026. This is a non-set-aside, competitively awarded contract to be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $80,243.07 to AmerisourceBergen Drug Corp for the supply of Mifepristone 300 mg tablets (quantity 28) on October 21, 2025, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F74HLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,680.71 to AmerisourceBergen Drug Corp for the supply of Misoprostol 200 microgram tablets in unit dose packaging (100 count) on January 30, 2026, with an ultimate completion date of February 2, 2026. The award is structured as a firm fixed-price contract with no set-aside designation, indicating competitive procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle held by AmerisourceBergen (through its parent company Cencora, Inc.) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. This prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including critical medications, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company's role as a major pharmaceutical distributor makes it a critical vendor for federal medical procurement supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/29/26 |